Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About the job About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent
Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich
Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich
The Position Are you passionate about innovation, finding cutting-edge solutions and creating value where it matters, around the globe? At the BI global Inflammation team, we strive to deliver innovative Therapeutic and patient centric solutions by
Principal, Health Economics, Health Technology Assessment IQVIA is The Human Data Science Company, focused on using data and science to help healthcare clients find better solutions for their patients. IQVIA offers a broad range of solutions
The Position At Boehringer Ingelheim, we are committed to transforming the lives of people living with cancer through breakthrough science and bold innovation. We are seeking a (Senior) Global Pricing & Access Manager to join our
_About the job_ About Sanofi Were an R&D-driven, AI-powered biopharma company committed to improving peoples lives and delivering compelling growth. Our deep understanding of the immune system - and innovative pipeline - enables us to invent
Global Medical Director, Evidence Generation Lead About This Role: As the Global Medical Director, Evidence Generation Lead, you will play a pivotal role in advancing data generation initiatives for the Dravet Syndrome therapeutic area. This position